Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05829343Recruiting

RObotic Versus LAparoscopic Colectomy for DIverticulitis.

Role: lead

NCT04686747Completed

COVID - 19 and Advanced Gastro-intestinal Cancer Treatment

Role: lead

NCT02985112Unknown

INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS)

Role: lead

NCT01971788Not ApplicableUnknown

The MATRIX OCT Substudy

Role: lead

NCT01243099Completed

Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo Lesions

Role: lead

NCT01014949Not ApplicableCompleted

Microcirculation Assessment in Diabetes and Metabolic Syndrome

Role: lead

All 6 trials loaded